Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Treasury ETF (SHV) Hits New 52-Week High

ByZacks Investment Research
Published 06/27/2019, 10:22 PM
Updated 07/09/2023, 06:31 AM

For investors seeking momentum, iShares Short Treasury Bond ETF (ASX:SHV) is probably on radar now. The fund just hit a 52-week high and is up 0.5% from its 52-week low price of $110.07/share.

But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:

SHV in Focus

SHV targets the short end of the yield curve. It holds 49 bonds in its basket with remaining maturities between one month and one year. It has a weighted average maturity of 0.35 years and effective duration of 0.34 years. It is a popular and liquid ETF in the Treasury space with AUM of $24.6 billion and charges 15 bps in annual fees. It has 2.17% in 30-day SEC yield (see: all the Government Bond ETFs here).

Why the Move?

The Treasury corner of the fixed income world has been an area to watch lately given a decline in yields. Escalating trade war tensions have raised global growth worries, thereby leading investors to safety in the bond market. Additionally, Fed’s cautious approach is also supporting the rally.

More Gains Ahead?

Currently, SHV has a Zacks ETF Rank #3 (Hold) with a Medium risk outlook, Therefore, it is hard to get a handle on its future returns one way or the other. However, a low weighted alpha of 0.30% and a low 20-day volatility of 0.67% for the ETF show that there is still some promise for risk-aggressive investors who want to ride on this surging ETF.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>

iShares Short Treasury Bond ETF (SHV): ETF Research Reports

Original post

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.